Imagine printing electronic circuits on flexible, recyclable materials like a newspaper instead of using rigid silicon chips. This project creates a toolkit of green components, including sensors and batteries powered by enzymes, that can be printed in long rolls. It's like moving from hand-crafting electronics to a high-speed printing press that doesn't harm the planet.
Traditional electronics rely on rigid, non-recyclable silicon and energy-intensive manufacturing. This creates environmental waste and limits the flexibility and cost-efficiency of wearable medical diagnostics.
A sustainable production platform for roll-to-roll manufacturing and a toolbox of components including flexible integrated circuits, bioenzymatic fuel cells, and low-power printed sensors.
If you are a medical device manufacturer dealing with the environmental waste of disposable sensors — this project developed a sustainable production platform for wound monitoring and blood sampling that reduces ecological impact.
If you are a point-of-care testing provider dealing with high costs of complex diagnostic hardware — this project developed low-power printed biosensors for protein and nucleic acid detection that are low-cost and lightweight.
If you are a health-tech wearable startup dealing with bulky batteries and rigid components — this project developed organic, recyclable bioenzymatic fuel cells and flexible integrated circuits to create autonomously operating systems.
The project focuses on roll-to-roll (R2R) manufacturing and sustainable materials to create low-cost, lightweight systems. Based on available project data, the use of printed electronics aims to reduce costs compared to traditional silicon-based systems.
Yes, the project specifically focuses on roll-to-roll (R2R) manufacturing, which is a high-volume industrial printing process designed for scalability.
Based on available project data, specific licensing terms are not mentioned, but the project delivers a 'toolbox' of technology components and a functional prototype for validation.
The project work performed in WP1 explicitly included ensuring regulatory compliance for medical use cases such as wound monitoring and blood sampling.
The project period runs from 2022-10-01 to 2026-03-31, suggesting that final validated prototypes will be available by early 2026.
The consortium is heavily industry-driven with a 64% industry ratio, comprising 7 industrial partners including 4 SMEs. Led by Medtronic Iberica, a major medical device player, the group spans 8 countries, ensuring a strong pipeline from academic research (2 universities, 2 research centers) to commercial application in the medical and electronics sectors.
Contact Medtronic Iberica SA regarding the SusFE toolbox for flexible ICs and biosensors.
Contact SciTransfer to explore licensing opportunities for the SusFE sustainable electronics toolbox.
